A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors.

Authors:
Anneke P Jilesen
Anneke P Jilesen
Radboud University Nijmegen Medical Center
Netherlands
Stefano Partelli
Stefano Partelli
University of Verona
Italy
Massimo Falconi
Massimo Falconi
Pancreas Translational & Clinical Research Center
Philadelphia | United States
Francesca Muffatti
Francesca Muffatti
San Raffaele Scientific Institute
Italy
Joanne Verheij
Joanne Verheij
Academic Medical Center

Ann Surg 2018 Jun;267(6):1148-1154

Department of Surgery, Academic Medical Center, Amsterdam, the Netherlands.

Objective: The aim of this study was to predict recurrence in patients with grade 1 or 2 nonfunctioning pancreatic neuroendocrine tumors (NF-pNET) after curative resection.

Background: Surgical resection is the preferred treatment for NF-pNET; however, recurrence occurs frequently after curative surgery, worsening prognosis of patients.

Methods: Retrospectively, patients with NF-pNET of 3 institutions were included. Patients with distant metastases, hereditary syndromes, or grade 3 tumors were excluded. Local or distant tumor recurrence was scored. Independent predictors for survival and recurrence were identified using Cox-regression analysis. The recurrence score was developed to predict recurrence within 5 years after curative resection of grade 1 to 2 NF-pNET.

Results: With a median follow-up of 51 months, 211 patients with grade 1 to 2 NF-pNET were included. Thirty-five patients (17%) developed recurrence. The 5- and 10-year disease-specific/overall survival was 98%/91% and 84%/68%, respectively. Predictors for recurrence were tumor grade 2, lymph node metastasis, and perineural invasion. On the basis of these predictors, the recurrence score was made. Discrimination [c-statistic 0.81, 95% confidence interval (95% CI) 0.75-0.87] and calibration (Hosmer Lemeshow Chi-square 11.25, P = 0.258) indicated that the ability of the recurrence score to identify patients at risk for recurrence is good.

Conclusions: This new scoring system could predict recurrence after curative resection of grade 1 and 2 NF-pNET. With the use of the recurrence score, less extensive follow-up could be proposed for patients with low recurrence risk. For high-risk patients, clinical trials should be initiated to investigate whether adjuvant therapy might be beneficial. External validation is ongoing due to limited availability of adequate cohorts.

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000002123DOI Listing
June 2018
69 Reads

Publication Analysis

Top Keywords

recurrence score
16
recurrence
14
predict recurrence
12
patients
8
neuroendocrine tumors
8
patients grade
8
predictors recurrence
8
curative resection
8
resection grade
8
grade nf-pnet
8
pancreatic neuroendocrine
8
nf-pnet recurrence
8
scoring system
8
system predict
8
grade
7
nf-pnet
5
98%/91% 84%/68%
4
84%/68% predictors
4
limited availability
4
recurrence tumor
4

Similar Publications